autoimmun
inflamm
cn
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
mediat
antigen
specif
cell
mani
year
integrin
target
block
helper
cell
traffick
cn
appear
attract
approach
treat
immunopatholog
ms
particular
monoclon
antibodi
natalizumab
subunit
integrin
heterodim
success
use
prevent
influx
immun
cell
cn
treat
cn
autoimmun
howev
experiment
model
shown
distinct
encephalitogen
cell
subset
vari
equip
cell
maintain
high
amount
express
cell
low
consequ
blockad
effici
prevent
recruit
cell
cell
cn
parenchyma
although
consid
immun
privileg
organ
cn
still
patrol
cell
mean
immun
surveil
contribut
vs
effector
memori
cell
migratori
resid
pool
lymphocyt
specif
given
pathogen
investig
skin
infect
unclear
cn
treatment
organ
specif
autoimmun
chronic
inflamm
effort
increas
market
compound
either
inhibit
immun
cell
traffick
cytokin
network
affect
distinct
helper
cell
subset
differenti
manner
antigmcsf
howev
preclin
model
investig
nich
specif
immun
surveil
host
defens
cn
rare
inde
efalizumab
block
antibodi
integrin
withdrawn
market
viral
mening
case
jc
viru
induc
progress
multifoc
leukencephalopathi
pml
establish
cn
specif
viral
infect
model
allow
us
analyz
contribut
distinct
helper
cell
subset
host
protect
chose
vaccinia
viru
vv
infect
import
viru
specif
helper
cell
respons
analyz
previous
vaccin
mice
found
protect
intrathec
ith
infect
vv
due
cellular
immun
absenc
cell
like
cell
suffici
protect
mice
intrathec
vv
infect
access
cell
infect
cn
compart
depend
express
although
viru
specif
cell
abl
migrat
cn
absenc
cn
recruit
infect
macrophag
clear
cell
sinc
cell
contrast
cell
defici
express
data
highlight
domin
role
cell
antivir
tissuespecif
immun
data
suggest
autoimmun
inflamm
cn
viru
specif
cell
depend
enter
cn
viru
infect
overcom
requir
cell
express
thu
integrin
target
therapeut
intervent
autoimmun
chronic
inflamm
need
refin
order
jeopard
organ
specif
immun
surveil
host
protect
mice
floxflox
mice
describ
previous
cre
mice
ifng
mice
mice
mice
wild
type
mice
obtain
jackson
laboratori
otii
mice
kindli
provid
dh
busch
institut
medic
microbiolog
immunolog
hygien
technisch
mous
strain
pure
background
mice
immun
subcutan
inject
emuls
iu
mva
pb
complet
freund
adjuv
cfa
vivo
blockad
mice
treat
everi
day
ip
inject
neutral
antibodi
bioxcel
west
lebanon
usa
isotyp
control
start
day
immun
similar
regimen
block
antibodi
integrin
bioxcel
west
lebanon
usa
deplet
antibodi
bioxcel
bioxcel
administ
everi
day
day
day
immun
respect
intrathec
infect
perform
previous
describ
brief
vv
inocul
cisterna
magna
mice
deep
anaesthesia
mean
transcutan
suboccipit
punctur
clinic
sign
diseas
well
weight
loss
percent
initi
weight
mean
sem
monitor
daili
adopt
transfer
experi
cell
isol
magnet
sort
cell
isol
kit
ii
mous
miltenyi
biotec
germani
otii
mice
differenti
vitro
cell
differenti
statu
check
day
intracellular
cytokin
stain
cytokin
posit
cell
inject
iv
recipi
mice
infect
vvova
one
day
prior
cell
transfer
anim
kept
specif
pathogenfre
facil
technisch
experiment
protocol
approv
stand
committe
experiment
laboratori
anim
bavarian
state
author
government
depart
upper
bavaria
approv
anim
experiment
propos
accord
german
law
experiment
laboratori
anim
carri
accord
correspond
guidelin
replic
compet
vv
western
reserv
strain
vv
provid
b
moss
nation
institut
health
bethesda
md
recombin
virus
encod
enhanc
green
fluoresc
protein
vv
egfp
fulllength
ovalbumin
vvova
base
western
reserv
strain
provid
jw
jewdel
jr
bennink
nation
institut
health
bethesda
md
vv
replic
defici
modifi
vaccinia
viru
ankara
strain
mva
clone
isol
iinew
use
studi
propag
titer
accord
standard
methodolog
cell
isol
lymph
node
spleen
magnet
sort
cell
isol
kit
ii
mous
miltenyi
biotec
germani
puriti
gener
higher
control
fac
stain
cell
stimul
day
platebound
antibodi
antibodi
recombin
cytokin
ad
differenti
cultur
indic
human
ngml
mous
ngml
mous
ngml
r
system
mononuclear
cell
isol
either
spleen
cn
peak
diseas
intrathec
challeng
perfus
left
cardiac
ventricl
cold
pb
brain
includ
cerebellum
dissect
spinal
cord
flush
pb
hydrostat
pressur
cn
tissu
digest
collagenas
mgml
roch
diagnost
indianapoli
dnasei
mgml
sigma
saint
loui
mo
min
mononuclear
cell
isol
pass
tissu
cell
strainer
percol
gradient
centrifug
mononuclear
cell
remov
interphas
wash
resuspend
cultur
medium
analysi
isol
mononuclear
cell
spleen
spleen
mash
cell
strainer
red
blood
cell
remov
use
bd
pharm
lyse
bd
bioscienc
surfac
stain
cell
carri
antibodi
antibodi
purchas
bd
bioscienc
fluorescencelabel
mhc
class
tsykfesv
multim
provid
dh
busch
cell
stimul
cultur
medium
contain
phorbol
pma
ngml
sigma
ionomycin
sigma
monensin
golgistop
bd
bioscienc
hour
stain
surfac
marker
cell
fix
permeabil
cytofixcytoperm
permwash
buffer
bd
bioscienc
follow
stain
monoclon
antibodi
mous
bd
bioscienc
flow
cytometr
analysi
cyan
beckmanncoult
detect
vvinfect
cell
macrophag
paraformaldehyd
pfa
fix
paraffin
embed
cn
tissu
section
incub
bond
primari
antibodi
diluent
leica
contain
either
polyclon
rabbit
antivv
serum
quartett
immunodiagnostika
vertriebsgmbh
berlin
monoclon
antibodi
purchas
bd
pharmingen
ihc
stain
perform
autom
leica
bondmax
instrument
use
bond
polym
refin
detect
solut
dab
detect
gfap
pfafix
paraffinembed
cn
section
incub
dako
polyclon
rabbit
antigfap
antibodi
ventana
buffer
stain
perform
ventana
nex
ihc
slide
stainer
use
iview
dab
detect
kit
ventana
imag
taken
use
leica
slide
scanner
analysi
softwar
acquir
olympu
microscop
camera
use
cellsen
digit
imag
softwar
olympu
quantit
pcr
rna
extract
magnet
beadpurifi
flow
cytometrysort
cell
ex
vivo
vitro
differenti
use
rneasi
column
qiagen
valencia
ca
complementari
dna
transcrib
recommend
appli
biosystem
foster
citi
ca
use
templat
quantit
pcr
primer
plu
probe
mixtur
obtain
appli
biosystem
taqman
analysi
perform
stepon
system
appli
biosystem
gene
express
normal
express
cell
lyse
denatur
use
ripa
buffer
sigmaaldrich
protein
lysat
separ
sdspage
nupag
bistri
mini
gel
transfer
nitrocellulos
membran
invitrogen
block
lowfat
dri
milk
tbst
membran
incub
primari
antibodi
abcam
abcam
block
solut
overnight
primari
antibodi
bind
detect
hrpconjug
secondari
antibodi
dianova
signal
visual
enhanc
chemiluminesc
novex
ecl
invitrogen
stain
spleen
mva
immun
cre
floxflox
cre
floxflox
mice
dissect
day
immun
singl
cell
suspens
prepar
cell
seed
well
flatbottom
plate
densiti
cellswel
singl
cell
restimul
mixtur
iabrestrict
vv
peptid
hour
presenc
brefeldin
last
hour
incub
follow
surfac
intracellular
stain
ebiosci
cytokin
indic
yqlfsdakancta
vkdkymwcysqvnkr
ftcdqgyhssdpnav
iskyaginilnvysp
obtain
biosyntan
berlin
pmig
eom
gfp
control
pmig
gfp
retrovir
construct
kind
gift
sl
reiner
univers
pennsylvania
philadelphia
pa
fj
quintana
harvard
medic
school
boston
phoenixeco
cell
pmid
kind
gift
hm
jaeck
erlangen
transient
transfect
plasmid
calcium
phosphat
precipit
presenc
chloroquin
sigma
aldrich
retrovir
supernat
collect
two
day
post
transfect
cell
transduc
hour
post
polyclon
vitro
activ
sort
cell
retrovir
supernat
polybren
merck
millipor
ad
precommit
cell
spin
transduct
perform
rpm
rt
hour
cell
cultur
day
polar
condit
gfp
express
cell
purifi
fac
sort
subject
quantit
pcr
analysi
cn
tissu
digest
describ
singl
cell
suspens
obtain
pass
digest
cn
tissu
nylon
filter
pellet
cell
subject
three
freezethaw
cycl
sonic
three
time
min
serial
dilut
medium
contain
fc
ad
duplic
confluent
cell
seed
plate
incub
hour
plaqu
count
crystal
violet
stain
mous
serum
sampl
collect
day
post
immun
mvacfa
pbscfa
serum
sampl
heatinactiv
min
prior
test
serum
dilut
incub
pfu
sucros
gradient
purifi
vv
egfp
hour
plate
cell
ad
infect
moi
carri
night
cell
harvest
wash
fix
paraformaldehyd
percentag
vvinfect
cell
determin
measur
egfp
express
flow
cytometr
analys
cyan
beckmanncoult
percentag
viru
neutral
defin
percentag
gfpexpress
cell
percentag
gfpexpress
cell
control
without
serum
statist
evalu
cell
frequenc
measur
gene
express
level
perform
unpair
student
test
twotail
p
valu
consid
signific
weight
score
given
mean
sem
multipl
comparison
perform
twowayanova
bonferroni
posttest
establish
model
viral
enceph
femal
mice
inject
intrathec
vv
suboccipit
punctur
cisterna
magna
titrat
dose
inoculum
half
lethal
dose
determin
approxim
plaqu
form
unit
pfu
figur
system
infect
vv
known
preferenti
replic
ovari
upon
hematogen
dissemin
therefor
measur
viral
load
cn
ovari
mice
inject
ith
pfu
vv
high
titer
vv
measur
cn
viru
detect
ovari
intrathec
infect
mice
figur
indic
intrathec
inject
vv
led
compartment
infect
within
cn
without
system
dissemin
within
cn
compart
vv
antigen
detect
ventricular
line
cell
plexu
epithelium
cell
well
astrocyt
glia
limitan
innat
immun
cell
monocyt
origin
recruit
infect
cn
compart
also
posit
vv
antigen
figur
order
determin
immun
cell
target
vv
within
cn
infect
wild
type
mice
recombin
vv
express
enhanc
green
fluoresc
protein
vv
egfp
analyz
egfp
express
distinct
cell
popul
cn
day
infect
found
sizabl
fraction
egfp
express
cell
within
macrophag
compart
figur
line
recent
studi
identifi
infiltr
inflammatori
monocyt
predomin
vv
infect
leukocyt
popul
vv
skin
infect
microgli
cell
cell
b
cell
show
egfp
express
addit
unabl
detect
egfp
express
cell
spleen
intrathec
inject
mice
demonstr
vv
infect
restrict
cn
compart
importantli
infect
macrophag
express
mhc
class
ii
figur
thu
phagocyt
cell
recruit
system
compart
respons
ith
vv
infect
becam
target
viru
replic
unabl
control
infect
see
figur
macrophag
becam
infect
vv
enceph
fail
elimin
viru
hypothes
adapt
cellular
immun
respons
requir
viru
control
order
investig
contribut
antigen
specif
effector
helper
cell
host
defens
ith
vv
infect
immun
wild
type
mice
replic
defici
strain
vv
mva
emulsifi
complet
freund
adjuv
cfa
day
prior
ith
challeng
vv
cfa
induc
respons
interest
investig
role
helper
cell
subset
tradeoff
host
protect
immunopatholog
infecti
enceph
shamimmun
mice
die
day
infect
larg
fail
recruit
either
helper
cell
vvspecif
ctl
cn
compart
figur
b
mva
immun
anim
harbor
antigen
specif
ctl
cell
cn
recov
vv
enceph
figur
ctl
reisol
cn
larg
produc
intrathec
effector
cell
compart
compris
produc
produc
doubl
produc
figur
summari
protect
immun
intrathec
vv
infect
associ
mobil
ctl
effector
helper
cell
cn
next
wish
dissect
specif
contribut
differ
cell
subset
protect
effect
vaccin
took
advantag
differenti
integrin
requir
recruit
cell
vs
cell
cn
compart
eae
model
cell
depend
order
enter
cn
autoimmun
inflamm
contrast
cell
abl
access
cn
compart
independ
use
depend
mechan
treat
mva
immun
mice
block
antibodi
integrin
prior
ith
vv
challeng
figur
notabl
mva
immun
mice
surviv
ith
vv
infect
spite
integrin
blockad
figur
expect
found
rel
abund
produc
cell
compar
posit
helper
cell
figur
find
support
idea
similar
cell
recruit
autoimmun
inflamm
cn
cell
cell
exhibit
distinct
integrin
requir
entri
cn
context
local
viru
infect
interestingli
absolut
number
cell
reduc
cn
larg
due
reduct
produc
effector
cell
number
ctl
recruit
cn
compart
significantli
reduc
antiintegrin
treat
mice
figur
thu
integrin
mediat
mechan
appear
redund
recruit
effector
cell
infect
cn
similar
murin
system
neutral
natalizumab
human
mainli
block
cell
enter
cn
compart
spare
cell
yet
intracerebr
reconstitut
effector
helper
cell
respons
propos
necessari
effici
clearanc
variou
virus
cn
includ
jc
viru
want
dissect
essenti
featur
intracerebr
helper
cell
respons
would
abl
control
viral
infect
thu
combin
system
cell
condit
ablat
express
cre
x
floxflox
mice
cko
mice
antibodi
mediat
deplet
cell
order
investig
differenti
contribut
cell
vs
cell
host
protect
cn
infect
absenc
ctl
exclud
possibl
alter
prime
antigen
specif
helper
cell
respons
peripher
immun
compart
cko
mice
compar
fraction
antigen
specif
cell
day
subcutan
immun
mvacfa
spleen
cre
x
floxflox
wild
type
control
versu
cre
x
floxflox
cko
mice
addit
file
figur
upon
ex
vivo
restimul
iab
restrict
vv
epitop
fraction
antigen
specif
cell
cytokin
profil
similar
wild
type
vs
cko
mice
moreov
antivv
neutral
serum
respons
equal
effect
group
day
immun
addit
file
figur
thu
sensit
adapt
cellular
immun
respons
vv
drain
lymph
node
spleen
impair
lack
cell
next
challeng
mva
immun
deplet
wild
type
cko
mice
ith
vv
contrast
control
litterm
cko
mice
rapidli
lost
weight
succumb
infect
figur
even
complet
absenc
cell
figur
effector
helper
cell
protect
wild
type
mice
fail
control
viru
replic
cn
cko
mice
figur
recapitul
observ
integrin
administr
defici
helper
cell
reisol
cn
vv
challeng
mice
exhibit
like
phenotyp
number
like
cell
significantli
reduc
cko
anim
compar
control
figur
e
consist
cytokin
product
upon
ex
vivo
stimul
cn
deriv
defici
helper
cell
express
higher
amount
signatur
marker
rorc
wherea
associ
gene
like
prevail
wild
type
helper
cell
figur
conclus
cell
appear
suffici
provid
host
protect
intrathec
vv
infect
cell
fail
control
cerebr
viru
replic
absenc
cell
result
lethal
enceph
corrobor
immun
suffici
improv
outcom
intrathec
viral
infect
establish
model
adopt
transfer
host
protect
use
otii
cell
carri
transgen
cell
receptor
specif
ovalbumin
combin
recombin
vv
express
ovalbumin
infect
cell
vvova
naiv
otii
cell
differenti
vitro
cell
cell
follow
transfer
mice
infect
intrathec
vvova
one
day
prior
adopt
transfer
figur
nontransf
defici
recipi
recipi
cell
rapidli
die
recipi
surviv
significantli
longer
counterpart
figur
despit
signific
differ
clinic
outcom
equal
amount
transfer
cell
cell
reisol
cn
infect
mice
figur
thu
per
cell
basi
antigen
specif
cell
appear
potent
allevi
ith
viru
infect
antigen
specif
cell
possibl
reduc
capac
cell
provid
host
protect
intrathec
vv
infect
simpli
due
reduc
avail
within
cn
compart
order
test
possibl
neutral
monoclon
antibodi
mva
immun
cell
deplet
wild
type
mice
addit
file
figur
pure
helper
cell
depend
scenario
vv
specif
cell
gener
access
vv
challeng
cn
notabl
mice
recov
vv
enceph
despit
ablat
effici
blockad
document
reduc
level
mhc
class
ii
express
microgli
cell
cn
compart
addit
file
figur
data
suggest
redund
effector
molecul
clearanc
intrathec
vv
infect
refut
idea
diminish
express
cell
respons
failur
clear
intracerebr
vv
infect
order
defin
potenti
molecular
mechan
helper
cell
mediat
host
protect
intracerebr
viral
infect
screen
express
profil
highli
purifi
effector
cell
isol
cn
vv
challeng
wild
type
vs
cko
mice
molecul
directli
involv
viru
defens
figur
effector
cell
express
tnf
grzmb
fasl
irrespect
whether
deriv
bias
inflammatori
infiltr
wild
type
mice
bias
inflammatori
milieu
cko
mice
contrast
express
markedli
reduc
defici
compar
wild
type
helper
cell
order
correl
lack
express
transcript
program
purifi
cell
mice
stimul
without
exogen
cytokin
differenti
cell
cell
figur
consist
vivo
data
found
signific
reduct
mrna
protein
compar
cell
notabl
protein
express
seen
late
time
point
figur
sinc
express
report
depend
express
transcript
factor
eomesodermin
eom
measur
rna
level
eom
cell
isol
brain
vv
infect
wild
type
cko
mice
consist
low
express
cell
eom
mrna
level
reduc
cell
isol
cko
mice
compar
wild
type
control
figur
formal
valid
whether
reduc
eom
express
cell
account
diminish
express
compar
cell
polar
cell
vitro
overexpress
eom
retrovir
transduct
figur
fac
sort
transduc
gfp
cell
express
abund
level
eom
compar
control
vector
prove
effect
transduct
concomitantli
rna
significantli
increas
eom
transduc
cell
data
suggest
failur
cell
express
due
reduc
eom
express
order
explor
import
cell
deriv
success
host
defens
cn
viru
infect
vivo
immun
defici
mice
mvacfa
establish
viral
enceph
cell
deplet
anim
intrathec
infect
vv
figur
wild
type
mice
recov
ith
vv
challeng
defici
mice
succumb
viral
enceph
number
fraction
cn
infiltr
immun
cell
compar
group
data
shown
indic
antigen
specif
prime
peripher
immun
compart
establish
inflammatori
infiltr
within
cn
impair
mice
moreov
wild
type
mice
vaccin
mva
deplet
cell
addit
cell
succumb
intrathec
challeng
vv
although
similar
fraction
nk
cell
nk
cell
cn
cell
replet
counterpart
addit
file
figur
suggest
altern
sourc
cell
insuffici
provid
protect
model
taken
togeth
data
demonstr
express
indispens
effector
helper
cell
mediat
control
intrathec
vv
infect
studi
test
concept
host
defens
viral
infect
cn
requir
distinct
helper
cell
subset
show
access
inhibit
cn
select
helper
cell
subset
integrin
target
intervent
result
failur
host
defens
intrathec
infect
vaccinia
viru
vv
control
vaccin
mice
cell
access
cn
compart
blockad
neutral
antibodi
cell
condit
disrupt
express
prevent
ctl
cell
enter
cn
parenchyma
cell
block
migrat
cn
ctl
deplet
host
defens
intrathec
vv
infect
still
maintain
long
effici
like
respons
oper
within
cn
contrast
cell
alon
fail
rescu
individu
cn
infect
despit
strong
inflammatori
respons
express
helper
cell
requir
clearanc
intrathec
vv
infect
cell
fail
elimin
vv
cn
due
lack
eom
depend
express
adapt
cellular
immun
respons
necessari
clearanc
system
vv
infect
cell
recogn
epitop
earli
antigen
vv
robust
cell
respons
also
requir
direct
indirect
antivir
effect
nich
restrict
organ
specif
infect
may
afford
specif
effector
function
exampl
vv
skin
infect
contain
clear
tempor
spatial
organ
interact
innat
immun
cell
ctl
ovari
clearanc
vv
correl
number
effector
memori
ctl
present
ovari
vv
immun
mice
challeng
viru
establish
intrathec
infect
model
vv
use
system
vivo
surrog
correl
access
distinct
helper
cell
subset
success
host
defens
intrathec
infect
naiv
wild
type
mice
vv
lethal
adapt
antivir
immun
respons
develop
upon
ith
infect
alon
although
innat
immun
cell
particular
monocyt
cell
recruit
infect
cn
activ
immun
mice
mva
cfa
prior
ith
vv
challeng
protect
anim
lethal
enceph
protect
independ
neutral
antibodi
howev
access
vv
specif
cell
cn
compart
necessari
suffici
host
protect
migrat
effector
cell
cn
mediat
chemokin
receptor
integrin
sever
cytolyt
noncytolyt
viral
infect
model
cn
use
investig
principl
immun
cell
recruit
cn
depend
viral
agent
immun
cell
recruit
cn
clear
pathogen
addit
caus
immunopathogen
tissu
damag
identifi
import
immun
cell
recruit
cn
west
nile
mhv
lcmv
infect
respect
chemotaxi
immun
cell
must
complement
integrin
mediat
interact
endotheli
cell
transmigr
immun
cell
across
blood
brain
barrier
earli
work
suggest
accumul
antigen
specif
cell
cn
compart
sindbi
viru
infect
anim
mediat
engag
use
genet
tool
recent
shown
distinct
helper
cell
subset
use
distinct
integrin
access
cn
compart
autoimmun
inflamm
entri
cell
subarachnoid
space
like
requir
independ
fact
cell
express
low
level
sinc
requir
cell
commit
inhibit
express
interestingli
antigen
specif
ctl
also
migrat
cn
independ
antibodi
blockad
cell
condit
genet
disrupt
consist
observ
cell
preferenti
reduc
csf
natalizumab
treat
patient
compar
cell
result
revers
csf
ratio
although
one
report
suggest
cell
influx
cn
prevent
block
antibodi
intracerebr
corona
viru
infect
model
unlik
recruit
antigen
specif
ctl
assess
ifergan
et
al
sinc
model
allow
activ
prime
activ
adapt
cell
respons
system
lymphoid
compart
prior
intracerebr
challeng
contrast
cell
express
indispens
nonredund
capac
antigen
experienc
cell
infiltr
subarachnoid
space
cn
compart
provid
evid
mhc
class
ii
posit
infect
phagocyt
cell
cn
need
clear
cell
order
rescu
mice
lethal
enceph
thu
mvaimmun
cell
condit
ko
mice
succumb
intrathec
vv
challeng
fail
recruit
cell
cn
despit
regular
cell
accumul
antigen
specif
cell
commun
viru
infect
macrophag
within
cn
parenchyma
elimin
infect
cell
suffici
express
ectromelia
infect
natur
mous
pox
infect
express
cell
requir
clear
pathogen
cell
mediat
kill
hematopoiet
mhc
class
ii
express
infect
target
cell
occur
drain
lymph
node
liver
spleen
direct
cytotox
effect
antigen
specif
cell
also
report
system
vv
infect
model
cell
condit
defici
mice
behav
like
defici
anim
succumb
infect
express
cell
reach
cn
compart
absenc
like
eae
cytokin
phenotyp
helper
cell
enter
cn
compart
absenc
show
profil
cell
express
initi
cell
commit
sensit
high
concentr
inhibit
differenti
contrast
promot
express
granzym
b
boost
cytotox
capac
cell
transcript
control
granzym
b
part
investig
cell
found
express
cell
associ
eom
overexpress
eom
cell
partial
reconstitut
express
similar
observ
report
cell
per
se
also
lack
correl
low
cytotox
efficaci
howev
lack
express
cell
may
mechan
impair
antivir
capac
exampl
cell
abl
mount
protect
respons
primari
lung
infect
influenza
ko
mice
suggest
cell
particularli
suscept
mediat
suppress
addit
induct
prosurviv
factor
cell
may
contribut
viral
persist
cn
theiler
viru
infect
convers
possibl
anatom
nich
cell
may
contribut
protect
antivir
immun
respons
eg
effect
mediat
recruit
neutrophil
lung
infect
also
produc
cell
might
role
modul
primari
recal
ctl
respons
increas
prolifer
reduc
sensit
exhaust
howev
overal
common
scenario
antivir
respons
fail
clear
viral
pathogen
rather
drive
deleteri
immunopatholog
skin
cornea
also
cn
shown
blockad
genet
lack
cell
select
modul
access
helper
cell
subset
cn
preferenti
limit
traffick
jeopard
host
defens
intrathec
vv
infect
nevertheless
experiment
system
sever
limit
first
ith
inocul
vv
repres
natur
rout
cn
infect
yet
immun
viru
antigen
cfa
provid
effici
way
gener
antigen
specif
respons
secondari
lymphoid
tissu
studi
traffick
effector
function
upon
ith
challeng
well
character
pathogen
second
ith
vv
infect
result
acut
encephalomyel
caus
rapid
decay
death
infect
anim
contrast
jc
viru
induc
pml
due
insuffici
control
latent
viru
infect
oligodendrocyt
howev
intracerebr
antijc
viru
cell
respons
contribut
substanti
jcv
control
effici
clearanc
jc
viru
cn
immun
reconstitut
washout
natalizumab
ms
patient
pml
associ
reoccurr
cell
cn
experiment
model
provid
mechanist
explan
insuffici
viru
control
condit
alter
cell
migrat
data
rais
concern
treatment
human
compound
like
natalizumab
interfer
cell
traffick
quantit
reduc
migrat
cell
cn
also
select
target
distinct
cell
subset
may
evok
seriou
defici
cellular
immun
respons
privileg
anatom
site
like
cn
result
primari
infect
unexpect
reactiv
latent
virus
may
facilit
data
set
support
result
articl
includ
within
articl
addit
file
author
declar
compet
interest
tk
vr
design
studi
wrote
manuscript
vr
contribut
equal
carri
experi
herein
support
gg
fp
sh
dhb
provid
fluorescencelabel
mhc
class
tsykfesv
multim
histolog
analys
carri
support
mh
group
gg
dhb
mh
bh
id
gave
concept
input
revis
manuscript
author
read
approv
final
manuscript
